Growth Metrics

Bionano Genomics (BNGO) Depreciation & Amortization (CF) (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 2.54% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.4 million through Dec 2025, down 16.39% year-over-year, with the annual reading at $9.5 million for FY2025, 32.06% down from the prior year.
  • Depreciation & Amortization (CF) hit $2.3 million in Q4 2025 for Bionano Genomics, up from $1.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.6 million in Q3 2023 to a low of $448000.0 in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $2.3 million across 5 years, with a median of $2.3 million in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): skyrocketed 393.3% in 2022 and later plummeted 36.74% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $1.9 million in 2021, then soared by 48.63% to $2.8 million in 2022, then skyrocketed by 30.01% to $3.6 million in 2023, then plummeted by 33.31% to $2.4 million in 2024, then fell by 2.54% to $2.3 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for BNGO at $2.3 million in Q4 2025, $1.8 million in Q3 2025, and $1.8 million in Q2 2025.